Citation Tools
PDFOriginal research
Institutional conflict of interest: attempting to crack the deferiprone mystery
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Institutional conflict of interest: attempting to crack the deferiprone mystery
Other content recommended for you
- Whistleblower’s decades long fight to save patients from dangerous research
- The Olivieri debacle: where were the heroes of bioethics?
- Biomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy
- Introduction to The Olivieri symposium
- Thalassaemia major: the murky story of deferiprone
- Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto
- Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board
- Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent β-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial
- Science, politics, ethics and the pandemic
- Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial